CORTESE, ROSA
 Distribuzione geografica
Continente #
EU - Europa 846
NA - Nord America 333
AS - Asia 41
OC - Oceania 2
SA - Sud America 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.226
Nazione #
US - Stati Uniti d'America 331
IE - Irlanda 322
SE - Svezia 116
IT - Italia 114
GB - Regno Unito 113
FR - Francia 66
ES - Italia 45
FI - Finlandia 26
DE - Germania 21
CN - Cina 8
IR - Iran 7
VN - Vietnam 7
IN - India 6
UA - Ucraina 6
HU - Ungheria 5
CH - Svizzera 4
TR - Turchia 4
MN - Mongolia 3
AL - Albania 2
AU - Australia 2
BR - Brasile 2
CA - Canada 2
HK - Hong Kong 2
LT - Lituania 2
PH - Filippine 2
AT - Austria 1
BE - Belgio 1
EU - Europa 1
ID - Indonesia 1
IL - Israele 1
NL - Olanda 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 1.226
Città #
Dublin 298
Southend 95
Siena 52
Chandler 49
Málaga 44
Princeton 31
Fairfield 23
Helsinki 23
Ashburn 20
Cambridge 13
Wilmington 11
Seattle 10
Woodbridge 10
Fremont 8
San Francisco 8
Dong Ket 7
Houston 7
Rome 6
Gyomro 5
San Diego 5
Florence 4
Jacksonville 4
London 4
Sacramento 4
Shanghai 4
Acquaviva delle Fonti 3
Ann Arbor 3
Bern 3
Ulan Bator 3
Acton 2
Andover 2
Bari 2
Boston 2
Brescia 2
Brunate 2
Central 2
Frankfurt am Main 2
General Santos 2
Hounslow 2
Kilburn 2
Lappeenranta 2
Leawood 2
Los Angeles 2
Malden 2
Menlo Park 2
Milan 2
Naples 2
New York 2
Poggibonsi 2
Radda in Chianti 2
Recanati 2
San Mateo 2
Sinalunga 2
Southwark 2
Toronto 2
Turin 2
Tübingen 2
Verona 2
Vilnius 2
Zanjan 2
Acireale 1
Ahmedabad 1
Americana 1
Bangalore 1
Beijing 1
Boardman 1
Bonndorf 1
Bratislava 1
Brussels 1
Canberra 1
Capalbio Scalo 1
Cascina 1
Caserta 1
Cavriglia 1
Chiswick 1
Colle di Val d'Elsa 1
Créteil 1
Delhi 1
Edinburgh 1
Empoli 1
Enfield 1
Falkenstein 1
Gaziemir 1
Giessen 1
Izmir 1
Jiaxing 1
Madrid 1
Melbourne 1
Migliarino Pisano 1
New Delhi 1
Newark 1
Nottuln 1
Padova 1
Parrano 1
Phoenix 1
Pietrasanta 1
Potenza 1
Pune 1
Saronno 1
Shenyang 1
Totale 859
Nome #
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study 204
Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalization 91
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course 55
MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies 44
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations 43
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 40
Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy) 38
Establishment of a clinician-led guideline on the diagnosis and treatment of Hirayama disease using a modified Delphi technique 35
Fatigue in multiple sclerosis: The role of thalamus 34
Gender Inequities in the Multiple Sclerosis Community: A Call for Action 34
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 33
Editorial: Cognition in Multiple Sclerosis 33
Clinical course of central nervous system demyelinating neurological adverse events associated with anti-TNF therapy 33
Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio 32
Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD 32
Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS technique 31
Advances in brain imaging in multiple sclerosis 31
Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging – Yes 30
Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis 30
Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study 29
Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets 27
Author Correction: High-dimensional detection of imaging response to treatment in multiple sclerosis (npj Digital Medicine, (2019), 2, 1, (49), 10.1038/s41746-019-0127-8) 27
MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease 26
A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B 25
Primary progressive multiple sclerosis presenting under the age of 18 years: Fact or fiction? 24
High-dimensional detection of imaging response to treatment in multiple sclerosis 23
Vessel-CAPTCHA: An efficient learning framework for vessel annotation and segmentation 23
Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis 23
Structural and Functional Connectivity Substrates of Cognitive Impairment in Multiple Sclerosis 20
Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis 19
Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data set 18
Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging 17
Cerebrospinal fluid neurofilament light chain levels: Marker of progression to generalized amyotrophic lateral sclerosis 17
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 16
Amyotrophic lateral sclerosis: A new missense mutation in the SOD1 gene 13
Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: A possible marker of disease severity and progression 12
Time to generalisation as a predictor of prognosis in amyotrophic lateral sclerosis 12
FOLR1 Gene Variation With Adult-Onset Cerebral Folate Deficiency and Stable Clinical and MRI Features up to 2 Years 11
A novel KIF5A mutation in an Italian family marked by spastic paraparesis and congenital deafness 11
Guiding differentiation of non-acute MOGAD from AQP4-NMOSD and RRMS using clinical and MRI measures 8
Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest 8
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 6
Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP) 4
Reversible splenial lesion and complex visual disturbances due to carbamazepine withdrawal 4
Hirayama disease: the importance of an early diagnosis 4
The role of imaging in Hirayama disease 4
Pregnancy and antibody-mediated CNS disorders: What do we know and what should we know? 3
Totale 1.337
Categoria #
all - tutte 9.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.213


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201914 0 0 0 0 0 0 0 0 0 0 8 6
2019/202048 4 3 2 3 5 6 5 6 7 3 2 2
2020/202168 2 2 1 2 3 6 3 11 10 12 7 9
2021/2022227 4 1 3 2 3 6 2 1 83 9 52 61
2022/2023528 25 36 78 47 20 86 71 41 47 46 14 17
2023/2024406 12 14 37 18 10 109 175 13 6 12 0 0
Totale 1.337